secwatch.observer — SEC 8-K summary
======================================

Issuer:     20/20 Biolabs, Inc. (AIDX)
CIK:        0001139685
Form:       8-K
Filed at:   2026-08-05T16:00:42+00:00
Accession:  0001213900-26-085514
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

20/20 Biolabs holds investor webinar on August 5, 2026; no specific financial or operational details released
--------------------------------------------------------------------------------

- Company furnished investor presentation for August 5, 2026 webinar under Regulation FD.
- Presentation materials are not incorporated by reference and are not deemed filed with the SEC.
- No financial results, guidance, or material events were disclosed in the filing text or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026085514/0001213900-26-085514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1139685/000121390026085514/ea0300726-8k_2020bio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-085514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer